Literature DB >> 35586768

Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan.

Hidetoshi Nomoto1,2, Kayoko Hayakawa1,3, Norio Ohmagari1,2,3.   

Abstract

The Japanese government implemented a large-scale vaccination policy against the coronavirus disease 2019 (COVID-19) pandemic, primarily using messenger RNA vaccines in 2021. Its hallmark was prioritized vaccination for the elderly after healthcare workers in a short period of time. Vaccination for the elderly, vulnerable to infection and severe disease, was carried out rapidly in approximately 4 months since April 2021. We evaluated the impact of Japan's vaccination policy against COVID-19 during the pandemic, with a particular focus on how prioritized vaccination for the elderly affected the pandemic. We observed a remarkable decrease in the number of infections, cluster events in long-term care facilities, and severe disease among the elderly during the fifth wave (August 2021) despite rising incidence of infections in the overall population. In conclusion, we think that prioritized vaccination for the elderly was efficacious in preventing infections and severe COVID-19 among the elderly during the fifth wave in Japan. 2022, National Center for Global Health and Medicine.

Entities:  

Keywords:  messenger RNA vaccines; pandemic; vaccination policy

Year:  2022        PMID: 35586768      PMCID: PMC9066456          DOI: 10.35772/ghm.2022.01015

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  7 in total

1.  Hospital capacity during the COVID-19 pandemic.

Authors:  Norihiro Kokudo; Haruhito Sugiyama
Journal:  Glob Health Med       Date:  2021-04-30

2.  Fairly Prioritizing Groups for Access to COVID-19 Vaccines.

Authors:  Govind Persad; Monica E Peek; Ezekiel J Emanuel
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

3.  The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.

Authors:  Peipei Song; Takashi Karako
Journal:  Biosci Trends       Date:  2021-12-28       Impact factor: 2.400

4.  The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.

Authors:  Kathleen Dooling; Mona Marin; Megan Wallace; Nancy McClung; Mary Chamberland; Grace M Lee; H Keipp Talbot; José R Romero; Beth P Bell; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

5.  Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan.

Authors:  Yusuke Asai; Hidetoshi Nomoto; Kayoko Hayakawa; Nobuaki Matsunaga; Shinya Tsuzuki; Mari Terada; Hiroshi Ohtsu; Koji Kitajima; Kumiko Suzuki; Tetsuya Suzuki; Keiji Nakamura; Shinichiro Morioka; Sho Saito; Fumitake Saito; Norio Ohmagari
Journal:  Gerontology       Date:  2022-01-07       Impact factor: 5.597

6.  Clusters of COVID-19 in long-term care hospitals and facilities in Japan from 16 January to 9 May 2020.

Authors:  Osamu Iritani; Tazuo Okuno; Daisuke Hama; Asami Kane; Kumie Kodera; Kozue Morigaki; Toshio Terai; Norie Maeno; Shigeto Morimoto
Journal:  Geriatr Gerontol Int       Date:  2020-07       Impact factor: 3.387

7.  First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.

Authors:  Sho Saito; Yusuke Asai; Nobuaki Matsunaga; Kayoko Hayakawa; Mari Terada; Hiroshi Ohtsu; Shinya Tsuzuki; Norio Ohmagari
Journal:  J Infect       Date:  2020-11-02       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.